Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New tweet just out from company: $GNCP GNCC Capital, Inc. (GNCP.PK) confirms that we are now in direct contact with OTC Compliance to be restored to PINK CURRENT. A Statement was just issued.
Ready to clear those 2s
I’m ready!
Anyone got thoughts on bottom here today. Assuming tun back on Monday
Wow, nice morning here
Damn this is moving!
We might want to start watching this!
Clear the 5s!
$GCLT nice climb!
Let it run folks, hit the ask
$HALB
Great morning here!
Good start to the day!
ALBO - PDUFA July 20th
Yuck! Everything is red today
Blowing through new highs!
The volume pattern is crazy consistent each month…makes no sense
Just need to clear the .001 and then she will fly!
Took a starter position
Twitter is on fire on this one
$bdgr tons of buys coming in, she’s about to start moving up!
Non stop buying going on here!
PRVB PDUFA Date Today!
PDUFA date July 20
ALBO PDUFA date July 20
Or today ; )
A girl can dream!
Let’s go! Been waiting
Thanks!
About to hit 52 week high!
Here she goes!
Goodness that’s a lot of volume today!
Same!
Ready for another good day here!
D8 Holdings, a Leader in THC Products, To Accept Bitcoin and Dogecoin
https://www.google.com/amp/s/www.thestreet.com/crypto/.amp/bitcoin/d8-holdings-to-accept-bitcoin-and-dogecoin
$PLX - PDUFA Date April 27, 2021
Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, and Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group.
Seeking accelerated approval of pegunigalsidase alfa (PRX–102) for the proposed treatment of adult patients with Fabry disease
Not much change overnight for DOGE day...